FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer
INGREDIENTS: Water, Centella Asiatica Extract (29.2%), Butylene Glycol, Propanediol, Niacinamide (20,000 ppm), Glycerin, Diethoxyethyl Succinate, Panthenol, Sodium Hyaluronate, Allantoin, Glutathione (1,000 ppm), Sodium Polyacryloyldimethyl Taurate, Glyceryl Acrylate/Acrylic Acid Copolymer, Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hydrolyzed Collagen, Squalane, Beta-Glucan, Dipropylene Glycol, Hippophae Rhamnoides Fruit Extract, Adenosine, Madecassic Acid, Asiaticoside, Asiatic Acid, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Glyceryl Stearate, Cholesterol, Styrene/Acrylates Copolymer, Cellulose Gum, Xanthan Gum, Inulin, Cellulose, Glucose, Fructose, Citric Acid, Disodium EDTA, Hydroxyacetophenone, 1,2-Hexanediol, Ethylhexylglycerin, Dipotassium Glycyrrhizate, Sodium Citrate MADE IN KOREA
I., Parker, S
Clinical trials of GLP-1-based medications have shown average reductions ranging from moderate to significant percentages of total body weight when combined with dietary changes
The glial limitans is denoted with white dotted lines
The supernatant was collected and stored at 80 C
